Co-funding Institute(s):
National Cancer Institute (NCI)
Translational Genomics of Neuroblastoma (TGiN) year 3
, October 2009
Bethesda North Marriott and Conference Center, Bethesda, MD, United States
Contact for additional information: Dr. Javed Khan, NCI 301-480-0314
DescriptionIdentify novel validated biomarkers for predicting prognosis. Identify and discuss novel targets Technology update Collaborative models Design of future collaborative study Database generation and data release. Discuss and confirm the funding mechanisms.